Your cart is currently empty!
Medical Device Clinical Study Reports (CSR)
Why Companies Choose NAMSA
Medical Device Clinical Trials Supported
Clinical Professionals on Staff
Therapeutic Areas in Which NAMSA Has Experience
Medical Writers on Staff with Advanced Degrees (MSc, PhD, MD)
Expertise in Writing Clinical Study Reports
Clinical Study Reports (CSRs) are pivotal to the success of clinical trials, serving as comprehensive documents that encapsulate the methods, results, and conclusions of a study. They are essential for regulatory submissions, providing the detailed evidence needed to demonstrate the safety and efficacy of a medical device. Beyond regulatory approval, CSRs are invaluable tools for sponsors, aiding in securing funding, supporting marketing efforts, and facilitating publication in scientific journals. By presenting a thorough and scientifically rigorous account of the clinical trial, CSRs help sponsors build credibility, attract investment, and ultimately bring innovative medical devices to market more efficiently.
A well-written medical device clinical trial CSR can speed up the approval process and market acceptance of a medical device. Conversely, a poorly written CSR can lead to delays, rejections, or unfavorable reviews. Therefore, it is crucial to have qualified medical writers who understand regulatory requirements, international standards, and industry best practices to elevate the quality of your report development.
Choose NAMSA For Medical Device CSR Development
- Expertise and Experience: We offer specialized knowledge and extensive experience in clinical research and regulatory requirements. Our team includes highly qualified professionals, many of whom hold advanced degrees such as PhDs or MDs. They ensure that your CSR is scientifically rigorous and fully compliant with all necessary guidelines.
- Efficiency and Speed: We have established processes and resources to create CSRs efficiently, significantly reducing the time required to complete the report. This helps you meet tight deadlines and speed up your marketing application.
- Quality Assurance: We implement robust quality control measures to ensure the accuracy and reliability of the data presented in your CSR. Our adherence to Good Clinical Practice (GCP) standards guarantees high-quality reports.
- Regulatory Compliance: Our team is well-versed in the regulatory landscape, ensuring that your CSR meets all local and international regulatory requirements. This is crucial for the approval and marketing of your medical device.
- Cost-Effectiveness: Outsourcing CSR creation to NAMSA can be more cost-effective than developing it in-house, especially for smaller companies that may not have the necessary resources or expertise.
- Focus on Core Activities: By outsourcing CSR creation to NAMSA, you can focus on your core activities, such as product development and marketing, while we handle the complex and time-consuming task of report preparation.
- Cross-Functional Approach: Our medical writing team prides itself on integrating seamlessly with the study team, allowing them to agilely understand the clinical study and the story you are trying to tell. This dedication to comprehending the narrative and study enables the team to identify issues early and resolve them with the study team before they are written into the CSR.
We Can Write Some or All Sections of Your Clinical Study Report
We are flexible and will work with your team as needed. We can assist in writing:
- Introduction: Background information on the medical device, the rationale for the study, and its objectives.
- Study Objectives and Endpoints: Specific goals of the study and the primary and secondary endpoints being measured.
- Study Design: Detailed description of the type of study (example: randomized controlled trial), methodology, and statistical considerations.
- Patient Population: Information about the study participants, including inclusion and exclusion criteria, demographics, and baseline characteristics.
- Intervention and Comparator: Details about the medical device being tested and any comparator treatments or controls used.
- Efficacy and Safety Results: Presentation of the study results, including statistical analyses of the primary and secondary endpoints, and safety data.
- Discussion and Conclusion: Interpretation of the results, including clinical significance, potential limitations of the study, and comparison with other studies. Summary of the key findings and their implications.
- Appendices: Additional information such as detailed statistical analyses, study protocols, and informed consent forms.
Feel free to contact us to learn more about how we can assist.
Meet Our Clinical Experts
Explore the depth of our team’s expertise in clinical study reporting.
-
Áine Mary Duffy, BSc (Hons), PhD
Clinical & Regulatory Operations ManagerView Bio -
Adam Saltman, PhD, MD
Principal Strategy Consultant, Clinical and Regulatory ServicesView Bio -
Aurélie San Juan, MSc, PhD
Principal Medical Writer, RegulatoryView Bio -
Britta Rupp, PhD
Clinical Strategy ConsultantView Bio -
Lucile Ryckebusch, PhD
Senior Medical Writer, IVDView Bio -
Séverine Oudin-Fantin, PhD
Manager–EMEA Medical Writing ServicesView Bio
Related Services That May Interest You
Biostatistics Consulting
Medical Writing
Clinical Trial Management
Frequently Asked Questions (FAQ)
What is your turn around time for CSR delivery?
The turnaround time for delivering a Clinical Study Report (CSR) depends on several factors, including data collection, query resolution, and the complexity of the study. To streamline the process, we start early by focusing on the CSR document shell and reviewing key information. This ensures that the tables, listings, and figures align with an agreed narrative with the sponsor. By gaining early approval on the layout, we can expedite the delivery of the final report.
Do you offer an interim CSR?
Yes.
How does NAMSA ensure data accuracy and consistency in Clinical Study Reports (CSRs) while maintaining a cohesive narrative throughout the report?
Our Medical Manager acts as a project manager, meticulously overseeing the details of the report to ensure data accuracy during compilation. They focus on maintaining a cohesive story throughout the reports, identifying and highlighting any discrepancies to the cross-functional teams for adjustment. Ideally, we engage as early as possible, around the last patient in (LPI) for enrollment or 2-3 months ahead of time, to involve the medical writer in understanding the study and establishing the shell and materials. This proactive approach helps streamline the process and ensures a high-quality CSR.
Do you provide Medical Writing if you do not run the trial?
Yes, NAMSA offers scalable solutions to meet our customers’ needs, whether it’s providing medical writers for one-off projects or longer-term contracts. Explore our outsourcing solutions to learn more about how we can support your clinical study report needs.
How do you integrate with the Study Management team when you are not running the trial?
If NAMSA is not involved, additional time is needed to understand team responsibilities and establish follow-up. Our medical writers, who typically hold advanced degrees such as PhDs and have analytical research backgrounds, will work closely with your team to establish a strong working relationship. We ensure that the information we compile accurately reflects the trial’s outcomes. If discrepancies arise, we will provide feedback to help generate the necessary supporting evidence, ensuring the CSR correctly details the trial results in a cohesive narrative.